Filing Details
GLAUKOS Corp (NYSE:GKOS) filed a Form 8-K with the Securities and Exchange Commission on November 06, 2026, disclosing a material event.
8k filedNYSE:GKOS
GLAUKOS Corp (GKOS) Reports Material Event to SEC
GLAUKOS Corp (NYSE:GKOS) filed a Form 8-K with the Securities and Exchange Commission on November 06, 2026, disclosing a material event.
At publication ·
What changed
GLAUKOS Corp (NYSE:GKOS) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- GLAUKOS Corp filed a Form 8-K with the SEC on November 6, 2026, disclosing a material event requiring shareholder awareness.
- The healthcare company's stock trades at $219.98 with a market capitalization of $6.3 billion.
- 8-K filings report significant events such as leadership changes, acquisitions, asset sales, or financial guidance updates between regular reports.
Market Context
GLAUKOS Corp's stock currently trades at $219.98 with a market capitalization of $6.3B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for GLAUKOS Corp's stock.
All SEC filings for GLAUKOS Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GKOS Stock Page
Frequently Asked Questions
Where can I read GKOS's SEC filings?
Browse all filings on our GKOS SEC filings page.
What types of SEC filings does GLAUKOS Corp file?
Public companies like GLAUKOS Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.